BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37333194)

  • 1. Functionally and metabolically divergent melanoma-associated macrophages originate from common bone-marrow precursors.
    Pizzurro GA; Bridges K; Jiang X; Vidyarthi A; Miller-Jensen K; Colegio OR
    bioRxiv; 2023 Jun; ():. PubMed ID: 37333194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally and Metabolically Divergent Melanoma-Associated Macrophages Originate from Common Bone-Marrow Precursors.
    Pizzurro GA; Bridges K; Jiang X; Vidyarthi A; Miller-Jensen K; Colegio OR
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging Leads to Increased Monocytes and Macrophages With Altered CSF-1 Receptor Expression and Earlier Tumor-Associated Macrophage Expansion in Murine Mesothelioma.
    Duong L; Pixley FJ; Nelson DJ; Jackaman C
    Front Aging; 2022; 3():848925. PubMed ID: 35821822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.
    Movahedi K; Laoui D; Gysemans C; Baeten M; Stangé G; Van den Bossche J; Mack M; Pipeleers D; In't Veld P; De Baetselier P; Van Ginderachter JA
    Cancer Res; 2010 Jul; 70(14):5728-39. PubMed ID: 20570887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.
    Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP
    Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.
    Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH
    J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
    Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
    Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages.
    Ahirwar DK; Charan M; Mishra S; Verma AK; Shilo K; Ramaswamy B; Ganju RK
    Cancer Res; 2021 Oct; 81(20):5255-5267. PubMed ID: 34400395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
    Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
    Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT of the union: dynamics of distinct tumor-associated macrophage subsets governed by STAT1.
    Van Overmeire E; Laoui D; Keirsse J; Bonelli S; Lahmar Q; Van Ginderachter JA
    Eur J Immunol; 2014 Aug; 44(8):2238-42. PubMed ID: 24975396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
    Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
    Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.
    Chen P; Huang Y; Bong R; Ding Y; Song N; Wang X; Song X; Luo Y
    Clin Cancer Res; 2011 Dec; 17(23):7230-9. PubMed ID: 21994414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation.
    Liu S; Zhang H; Li Y; Zhang Y; Bian Y; Zeng Y; Yao X; Wan J; Chen X; Li J; Wang Z; Qin Z
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of Tumor-Associated Macrophages.
    Laviron M; Boissonnas A
    Front Immunol; 2019; 10():1799. PubMed ID: 31417566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic glycolysis is a metabolic requirement to maintain the M2-like polarization of tumor-associated macrophages.
    M de-Brito N; Duncan-Moretti J; C da-Costa H; Saldanha-Gama R; Paula-Neto HA; G Dorighello G; L Simões R; Barja-Fidalgo C
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118604. PubMed ID: 31760090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Model of the Early Melanoma Microenvironment Captures Macrophage Transition into a Tumor-Promoting Phenotype.
    Pizzurro GA; Liu C; Bridges K; Alexander AF; Huang A; Baskaran JP; Ramseier J; Bosenberg MW; Mak M; Miller-Jensen K
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt Signaling in the Phenotype and Function of Tumor-Associated Macrophages.
    Tigue ML; Loberg MA; Goettel JA; Weiss WA; Lee E; Weiss VL
    Cancer Res; 2023 Jan; 83(1):3-11. PubMed ID: 36214645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.
    Piña Y; Boutrid H; Murray TG; Jager MJ; Cebulla CM; Schefler A; Ly LV; Alegret A; Celdran M; Feuer W; Jockovich ME
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2671-7. PubMed ID: 20053982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.